Trial Profile
Phase 2 study of AZP2006 in patients with frontotemporal dementia (FTD)
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 27 Oct 2015
Price :
$35
*
At a glance
- Drugs Ezeprogind (Primary)
- Indications Dementia
- Focus Therapeutic Use
- Sponsors AlzProtect
- 27 Oct 2015 New trial record